{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:04:02Z","timestamp":1791993842821,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1194,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1038\/mt.2013.61","type":"journal-article","created":{"date-parts":[[2013,5,14]],"date-time":"2013-05-14T08:20:24Z","timestamp":1368519624000},"page":"1432-1444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Induction of Broad Cytotoxic T Cells by Protective DNA Vaccination Against Marburg and Ebola"],"prefix":"10.1016","volume":"21","author":[{"given":"Devon J","family":"Shedlock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Aviles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendra T","family":"Talbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan J","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel O","family":"Villarreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin JF","family":"Myles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A","family":"Croyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary P","family":"Kobinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2013.61_bib1","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"Feldmann","year":"2011","journal-title":"Lancet"},{"key":"10.1038\/mt.2013.61_bib2","doi-asserted-by":"crossref","first-page":"e1546","DOI":"10.1371\/journal.pntd.0001546","article-title":"Ebola and Marburg hemorrhagic fevers: neglected tropical diseases?","volume":"6","author":"MacNeil","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1038\/mt.2013.61_bib3","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","author":"Borio","year":"2002","journal-title":"JAMA"},{"key":"10.1038\/mt.2013.61_bib4","first-page":"984241","article-title":"Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever","volume":"2011","author":"Warfield","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1038\/mt.2013.61_bib5","doi-asserted-by":"crossref","first-page":"e837","DOI":"10.1371\/journal.pntd.0000837","article-title":"Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis","volume":"4","author":"Wauquier","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1038\/mt.2013.61_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1586\/erv.10.152","article-title":"Progress in filovirus vaccine development: evaluating the potential for clinical use","volume":"10","author":"Falzarano","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1038\/mt.2013.61_bib7","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4049\/jimmunol.175.2.1184","article-title":"Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection","volume":"175","author":"Warfield","year":"2005","journal-title":"J Immunol"},{"key":"10.1038\/mt.2013.61_bib8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.virusres.2011.09.005","article-title":"Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses","volume":"162","author":"Grant-Klein","year":"2011","journal-title":"Virus Res"},{"key":"10.1038\/mt.2013.61_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1743-422X-6-132","article-title":"Discovery of common marburgvirus protective epitopes in a BALB\/c mouse model","volume":"6","author":"Kalina","year":"2009","journal-title":"Virol J"},{"key":"10.1038\/mt.2013.61_bib10","doi-asserted-by":"crossref","first-page":"14189","DOI":"10.1128\/JVI.79.22.14189-14196.2005","article-title":"Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins","volume":"79","author":"Olinger","year":"2005","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.61_bib11","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nm.2447","article-title":"CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates","volume":"17","author":"Sullivan","year":"2011","journal-title":"Nat Med"},{"key":"10.1038\/mt.2013.61_bib12","doi-asserted-by":"crossref","first-page":"10386","DOI":"10.1128\/JVI.00594-10","article-title":"Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates","volume":"84","author":"Geisbert","year":"2010","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.61_bib13","doi-asserted-by":"crossref","first-page":"e44769","DOI":"10.1371\/journal.pone.0044769","article-title":"Designing and testing broadly-protective filoviral vaccines optimized for cytotoxic T-lymphocyte epitope coverage","volume":"7","author":"Fenimore","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1038\/mt.2013.61_bib14","doi-asserted-by":"crossref","first-page":"e1000904","DOI":"10.1371\/journal.ppat.1000904","article-title":"Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species","volume":"6","author":"Hensley","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1038\/mt.2013.61_bib15","doi-asserted-by":"crossref","first-page":"e44115","DOI":"10.1371\/journal.pone.0044115","article-title":"Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species","volume":"7","author":"Zahn","year":"2012","journal-title":"PLoS ONE"},{"issue":"Suppl 3","key":"10.1038\/mt.2013.61_bib16","doi-asserted-by":"crossref","first-page":"S1075","DOI":"10.1093\/infdis\/jir349","article-title":"Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections","volume":"204","author":"Geisbert","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1038\/mt.2013.61_bib17","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.4161\/hv.21873","article-title":"A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge","volume":"8","author":"Grant-Klein","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1038\/mt.2013.61_bib18","doi-asserted-by":"crossref","first-page":"155ra138","DOI":"10.1126\/scitranslmed.3004414","article-title":"Immunotherapy against HPV16\/18 generates potent TH1 and cytotoxic cellular immune responses","volume":"4","author":"Bagarazzi","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1038\/mt.2013.61_bib19","series-title":"Clinical Aspects of Electroporation","author":"Kee","year":"2011"},{"key":"10.1038\/mt.2013.61_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/infdis\/jiq017","article-title":"Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge","volume":"203","author":"Hirao","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1038\/mt.2013.61_bib21","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.4161\/hv.22447","article-title":"Vaccination with synthetic constructs expressing cytomegalovirus immunogens is highly T cell immunogenic in mice","volume":"8","author":"Shedlock","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1038\/mt.2013.61_bib22","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1128\/JVI.00069-06","article-title":"Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola","volume":"80","author":"Towner","year":"2006","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.61_bib23","doi-asserted-by":"crossref","first-page":"e1001098","DOI":"10.1371\/journal.ppat.1001098","article-title":"Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein","volume":"6","author":"Francica","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1038\/mt.2013.61_bib24","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1182\/blood-2010-12-322727","article-title":"Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression","volume":"117","author":"Hersperger","year":"2011","journal-title":"Blood"},{"key":"10.1038\/mt.2013.61_bib25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/35046108","article-title":"Development of a preventive vaccine for Ebola virus infection in primates","volume":"408","author":"Sullivan","year":"2000","journal-title":"Nature"},{"key":"10.1038\/mt.2013.61_bib26","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1128\/JVI.02098-06","article-title":"Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines","volume":"81","author":"Dowling","year":"2007","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.61_bib27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/viro.1998.9176","article-title":"DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge","volume":"246","author":"Vanderzanden","year":"1998","journal-title":"Virology"},{"key":"10.1038\/mt.2013.61_bib28","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1016\/S0264-410X(03)00362-1","article-title":"Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus","volume":"21","author":"Riemenschneider","year":"2003","journal-title":"Vaccine"},{"key":"10.1038\/mt.2013.61_bib29","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.vaccine.2004.11.070","article-title":"Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections","volume":"23","author":"Swenson","year":"2005","journal-title":"Vaccine"},{"key":"10.1038\/mt.2013.61_bib30","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.virol.2005.10.042","article-title":"Chimpanzee adenovirus vaccine protects against Zaire Ebola virus","volume":"346","author":"Kobinger","year":"2006","journal-title":"Virology"},{"issue":"Suppl 2","key":"10.1038\/mt.2013.61_bib31","doi-asserted-by":"crossref","first-page":"S404","DOI":"10.1086\/520591","article-title":"Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever","volume":"196","author":"Jones","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1038\/mt.2013.61_bib32","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1128\/JVI.02098-06","article-title":"Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines","volume":"81","author":"Dowling","year":"2007","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.61_bib33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.virol.2010.02.029","article-title":"Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms","volume":"401","author":"Shedlock","year":"2010","journal-title":"Virology"},{"key":"10.1038\/mt.2013.61_bib34","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1371\/journal.pmed.0030177","article-title":"Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs","volume":"3","author":"Sullivan","year":"2006","journal-title":"PLoS Med"},{"key":"10.1038\/mt.2013.61_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm0198-037","article-title":"Immunization for Ebola virus infection","volume":"4","author":"Xu","year":"1998","journal-title":"Nat Med"},{"key":"10.1038\/mt.2013.61_bib36","doi-asserted-by":"crossref","first-page":"S430","DOI":"10.1086\/520583","article-title":"Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge","volume":"196 Suppl 2","author":"Warfield","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1038\/mt.2013.61_bib37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2008.09.020","article-title":"Protection against lethal challenge by Ebola virus-like particles produced in insect cells","volume":"383","author":"Sun","year":"2009","journal-title":"Virology"},{"key":"10.1038\/mt.2013.61_bib38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1021\/mp200392g","article-title":"A single sublingual dose of an adenovirus-based vaccine protects against lethal Ebola challenge in mice and guinea pigs","volume":"9","author":"Choi","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1038\/mt.2013.61_bib39","doi-asserted-by":"crossref","first-page":"e5308","DOI":"10.1371\/journal.pone.0005308","article-title":"Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine","volume":"4","author":"Richardson","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1038\/mt.2013.61_bib40","doi-asserted-by":"crossref","first-page":"10605","DOI":"10.1128\/JVI.00558-11","article-title":"Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses","volume":"85","author":"Blaney","year":"2011","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.61_bib41","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00430-012-0268-8","article-title":"Immune control in the absence of immunodominant epitopes: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells","volume":"201","author":"Ebert","year":"2012","journal-title":"Med Microbiol Immunol"},{"key":"10.1038\/mt.2013.61_bib42","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.4049\/jimmunol.1001606","article-title":"Responses against a subdominant CD8+ T cell epitope protect against immunopathology caused by a dominant epitope","volume":"185","author":"Ruckwardt","year":"2010","journal-title":"J Immunol"},{"key":"10.1038\/mt.2013.61_bib43","doi-asserted-by":"crossref","first-page":"e2517","DOI":"10.1371\/journal.pone.0002517","article-title":"Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens","volume":"3","author":"Laddy","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1038\/mt.2013.61_bib44","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.mt.6300036","article-title":"Enhanced cellular immune responses elicited by an engineered HIV-1 subtype B consensus-based envelope DNA vaccine","volume":"15","author":"Yan","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.61_bib45","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.4161\/hv.22447","article-title":"Vaccination with synthetic constructs expressing cytomegalovirus immunogens is highly T cell immunogenic in mice","volume":"8","author":"Shedlock","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1038\/mt.2013.61_bib46","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.clim.2011.08.008","article-title":"Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies","volume":"141","author":"Qiu","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1038\/mt.2013.61_bib47","doi-asserted-by":"crossref","first-page":"S1032","DOI":"10.1093\/infdis\/jir332","article-title":"Impact of systemic or mucosal immunity to adenovirus on Ad-based Ebola virus vaccine efficacy in guinea pigs","volume":"204 Suppl 3","author":"Richardson","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1038\/mt.2013.61_bib48","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1086\/520612","article-title":"Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents","volume":"196 Suppl 2","author":"Warfield","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1038\/mt.2013.61_bib49","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1128\/JVI.76.18.9176-9185.2002","article-title":"Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells","volume":"76","author":"Rao","year":"2002","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.61_bib50","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1016\/S0264-410X(99)00170-X","article-title":"Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by immunization with liposomes containing lipid A","volume":"17","author":"Rao","year":"1999","journal-title":"Vaccine"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616319670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616319670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:51:11Z","timestamp":1761501071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616319670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1525001616319670"],"URL":"https:\/\/doi.org\/10.1038\/mt.2013.61","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of Broad Cytotoxic T Cells by Protective DNA Vaccination Against Marburg and Ebola","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mt.2013.61","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The American Society of Gene & Cell Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}